Dr. Eng shared her expertise on the FRESCO2 study, the integration of Fruquintinib into current treatment regimens, and the significance of circulating tumor DNA. We also explore the benefits of attending oncology conferences, both in-person and virtually, for residents, fellows, and community oncologists.